These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2685118)

  • 21. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigen processing and the human T cell receptor repertoire for insulin.
    Miller GG; Hoy JF; Nell LJ; Thomas JW
    J Immunol; 1988 Nov; 141(10):3293-8. PubMed ID: 2460529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein synthesis in antigen processing.
    Jensen PE
    J Immunol; 1988 Oct; 141(8):2545-50. PubMed ID: 3049813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
    Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
    Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.
    Ronchese F; Brown MA; Germain RN
    J Immunol; 1987 Jul; 139(2):629-38. PubMed ID: 3110276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
    Guéry JC; Adorini L
    J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted response.
    Langton BC; Mackewicz CE; Wan AM; Andria ML; Benjamini E
    J Immunol; 1988 Jul; 141(2):447-56. PubMed ID: 3260252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.
    Carayanniotis G; Barber BH
    Nature; 1987 May 7-13; 327(6117):59-61. PubMed ID: 3472080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
    Semple JW; Ellis J; Delovitch TL
    J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major histocompatibility complex-restricted and unrestricted activation of helper T cell lines by liposome-bound antigens.
    Walden P; Nagy ZA; Klein J
    J Mol Cell Immunol; 1986; 2(4):191-7. PubMed ID: 2978228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isotypic residues in the membrane proximal domain of MHC class II beta-chains control activation of CD4+ T cells.
    Sant AJ
    J Immunol; 1993 Jun; 150(12):5299-310. PubMed ID: 8099935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of antigen processing to the recognition of a synthetic peptide antigen by specific T cell hybridomas.
    Boyer M; Novak Z; Fotedar A; Singh B
    J Mol Recognit; 1988 Apr; 1(2):99-106. PubMed ID: 3152567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC.
    Jensen PE
    J Immunol; 1993 Apr; 150(8 Pt 1):3347-56. PubMed ID: 8385684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of antigen processing and presentation by resting B lymphocytes.
    Gosselin EJ; Tony HP; Parker DC
    J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.